Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Osteoporosis in Childhood Cancer Survivors
NCT00391404Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Percent change in bone mineral density at lumbar spine at 36 weeks. Status: unknown.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00391404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391404.